Bloomberg Closes Acquisition of Barclays Risk Analytics and Index Solutions

Acquisition includes Barclays fixed-income benchmark indices, Brais strategy indices, and the intellectual property of Point portfolio analytics.

Bloomberg will integrate the Brais indices into its existing analytics solutions.

Bloomberg has completed the acquisition of Barclays’ Risk Analytics and Index Solutions (Brais) business as the data vendor seeks to bolster its analytics and indices capabilities.

The acquisition includes the Barclays fixed-income benchmark indices, Brais strategy indices, and the intellectual property of the Point portfolio analytics solution.

The Brais indices will be integrated into Bloomberg's analytic dashboards, portfolio analytics, order management systems (OMSs), and execution management systems (EMSs) in the Bloomberg Commodity Index and AusBond Indices. The indices will be rebranded as Bloomberg Barclays Indicies for an initial period of five years.

Bloomberg will also incorporate models and analytics from Point into Bloomberg Port and augment these with data, news, alerts, mobile capabilities, and Bloomberg's order management solutions. Barclays will continue to operate the Point solution for a further 18-month period to ease client transition.

"Properly constructed benchmark and strategy indices, and state-of-the-art analytics, continue to grow in importance to the investment community as the global markets evolve in a fast-changing regulatory environment," said JP Zammitt, global head of financial products at Bloomberg, in a statement. "Bloomberg is committed to being at the forefront of these developments, and is well-positioned to grow and evolve the Brais business for a broader set of market participants."

As was previously reported, the fixed-income community has expressed concern of the looming Barclays Point retirement after the Brais acquisition. 

  • LinkedIn  
  • Save this article
  • Print this page  

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: